Seeking to expand targeted therapy for lung cancer
NIH MERIT Award will support Dr. Alice Berger’s efforts to target lung cancer-associated gene mutation April 7, 2021 • By Sabrina Richards / Fred Hutch News Service Dr. Alice Berger works to expand targeted therapy options for patients with lung cancer. Photo by Robert Hood / Fred Hutch News Service
Targeted therapies have transformed outcomes for lung cancer patients. After reduced smoking rates, drugs that take aim at signature alterations in tumor cells are the main reason that the death rate has dropped for people diagnosed with lung cancer. Recently, Fred Hutchinson Cancer Research Center lung cancer researcher Dr. Alice Berger received a National Institutes of Health MERIT Award that will support her efforts to extend these advances to more patients with this cancer.
St Elizabeth Healthcare is an Early Contributor in Nationwide COVID-19 and Cancer Consortium Study; Published in Annals of Oncology
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Australian Red Cross - 758 Words
123helpme.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from 123helpme.com Daily Mail and Mail on Sunday newspapers.